Sort
15,842 grants matching “pancreatic cancer”
Tumor Biology Research Program
$36,630Priyamvada Rai · University Of Miami School Of Medicine · P30 · FY2025 · CA
Tumor Biology Research Program
$36,549Anil K Rustgi · University Of Pennsylvania · P30 · FY2017 · CA
Validation of WEE1 kinase as a clinical target in KRAS-mutant pancreatic cancer
$36,523John Nathaniel Diehl · Univ Of North Carolina Chapel Hill · F30 · FY2019 · CA
Development of Gli1-Selective Therapeutics for Hedgehog Pathway-Dependent Cancers
$36,498Alison Evelynn Ondrus · Stanford University · F32 · FY2016 · CA
Tumor Biology Research Program
$36,443Anil K Rustgi · University Of Pennsylvania · P30 · FY2016 · CA
Translational Oncology
$36,416Raymond C Bergan · Oregon Health & Science University · P30 · FY2020 · CA
The role of branched-chain amino acid metabolism and hyperinsulinemia in pancreatic cancer
$36,413Michael Noji · University Of Pennsylvania · F31 · FY2024 · CA
Enhancing the efficacy of 5 fluorouracil using emodin as a complementary therapeutic
$36,409Alexander Theodore Sougiannis · University Of South Carolina At Columbia · F31 · FY2019 · AT
The Role of Cancer Associated Fibroblasts in Pancreatic Tumor Progression
$36,366Jason R. Pitarresi · Ohio State University · F31 · FY2015 · CA
Function of TbRIII as a BMP Co-receptor in Human Cancer
$36,347Gerard C Blobe · Duke University · R01 · FY2012 · CA
Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO
$36,333Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
Synthesis, and Evaluation of Potent and Selective MEK4 Inhibitors as a Targeted Therapeutic for Metastatic Pancreatic Ductal Adenocarcinoma
$36,331Ada Jade Kwong · Northwestern University · F31 · FY2021 · CA
Elucidating fibroblast/immune crosstalk and plasticity in pancreatic ductal adenocarcinoma
$36,307Jennifer Susan Thalappillil · State University New York Stony Brook · F31 · FY2021 · CA
Role of hedgehog signaling in tumor-associated macrophage polarization
$36,288Amy Jiayue Petty · Duke University · F30 · FY2019 · CA
Dissecting the role of the immune system in the radiation response of Kras-mutant tumors
$36,288Amy Jordan Wisdom · Duke University · F30 · FY2019 · CA
Promoting Activated Natural Killer (NK) Cell Accumulation in Pancreatic Cancer
$36,274Alexander Lekan · Georgetown University · F30 · FY2024 · CA
Ligand-Receptor Interactions in the TGF-beta superfamily
$36,190Andrew P Hinck · University Of Texas Hlth Science Center · R01 · FY2009 · GM
TGF-Beta signaling and microRNA processing: Implications for invasion and metasta
$36,179Ana Clara Pereira Azevedo-Pouly · Ohio State University · F31 · FY2012 · CA
A combined single cell gene expression and enzyme activity assay to study chemotherapy resistance in pancreatic ductal adenocarcinoma
$36,173Brae Petersen · Univ Of North Carolina Chapel Hill · F31 · FY2019 · CA
Identifying targets for combination therapy with FOLFIRINOX and investigating cell polarity loss as a potential driver of invasion in basal-like PDAC
$36,112Sandra Zarmer · Univ Of North Carolina Chapel Hill · F31 · FY2023 · CA
Dissecting how activated immunity reshapes the stromal TME of pancreatic ductal adenocarcinoma
$36,046Blake Sells · Washington University · F30 · FY2025 · CA
Immunological Targeting of Colon Cancer Stem Cells
$35,900Tyler R. Prestwood · Stanford University · F30 · FY2016 · CA
Mechanisms of Venous Thromboembolism in Cancer
$35,855Nigel Mackman · Univ Of North Carolina Chapel Hill · R01 · FY2012 · HL
The Opioid Cohort Consortium (OPICO) to investigate the effects of using opioids on cancer risk
$35,845Mahdi Sheikh · International Agency For Res On Cancer · U01 · FY2025 · CA
Determining the Role of Discoidin Domain Receptor 2 in the Pathogenesis of Pancreatic Ductal Adenocarcinoma
$35,826Jeanine Ruggeri · University Of Michigan At Ann Arbor · F31 · FY2018 · CA